Merck Shares Outstanding 2012-2026 | MRK

Merck shares outstanding for the quarter ending March 31, 2026 were 2.472B, a 2.33% decline year-over-year.

  • Merck 2025 shares outstanding were 2.507B, a 1.34% decline from 2024.
  • Merck 2024 shares outstanding were 2.541B, a 0.24% decline from 2023.
  • Merck 2023 shares outstanding were 2.547B, a 0.2% increase from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Merck Shares Outstanding 2012-2026 | MRK

  • Merck 2025 shares outstanding were 2.507B, a 1.34% decline from 2024.
  • Merck 2024 shares outstanding were 2.541B, a 0.24% decline from 2023.
  • Merck 2023 shares outstanding were 2.547B, a 0.2% increase from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B